Skip to main page content
Accesskeys

dbSNP Short Genetic Variations

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs1042714

Current Build 153

Released July 9, 2019

Organism
Homo sapiens
Position
chr5:148826910 (GRCh38.p12) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
G>C / G>T
Variation Type
SNV Single Nucleotide Variation
Frequency
G=0.31653 (79582/251422, GnomAD_exome)
G=0.31228 (39213/125568, TOPMED)
G=0.31662 (38431/121380, ExAC) (+ 6 more)
G=0.1979 (15566/78666, PAGE_STUDY)
G=0.3317 (10402/31360, GnomAD)
G=0.204 (1023/5008, 1000G)
G=0.424 (1899/4480, Estonian)
G=0.07 (42/614, Vietnamese)
G=0.41 (244/600, NorthernSweden)
Clinical Significance
Reported in ClinVar
Gene : Consequence
ADRB2 : Stop Gained
Publications
150 citations
Genomic View
See rs on genome
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p12 chr 5 NC_000005.10:g.148826910G>C
GRCh38.p12 chr 5 NC_000005.10:g.148826910G>T
GRCh37.p13 chr 5 NC_000005.9:g.148206473G>C
GRCh37.p13 chr 5 NC_000005.9:g.148206473G>T
ADRB2 RefSeqGene NG_016421.1:g.5318C>G
ADRB2 RefSeqGene NG_016421.1:g.5318C>T
Gene: ADRB2, adrenoceptor beta 2 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
ADRB2 transcript NM_000024.5:c.79C>G Q [CAA] > E [GAA] Coding Sequence Variant
beta-2 adrenergic receptor NP_000015.1:p.Gln27Glu Q (Gln) > E (Glu) Missense Variant
ADRB2 transcript NM_000024.5:c.79C>T Q [CAA] > * [TAA] Coding Sequence Variant
beta-2 adrenergic receptor NP_000015.1:p.Gln27Ter Q (Gln) > * (Ter) Stop Gained
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: G= (allele ID: 32782 )
ClinVar Accession Disease Names Clinical Significance
RCV000019318.2 Asthma, childhood, susceptibility to Risk-Factor
RCV000019319.2 Metabolic syndrome, susceptibility to Risk-Factor
RCV000033191.3 ADRB2 POLYMORPHISM Benign
Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
gnomAD - Exomes Global Study-wide 251422 G=0.31653 C=0.68347
gnomAD - Exomes European Sub 135356 G=0.42017 C=0.57983
gnomAD - Exomes Asian Sub 49008 G=0.1656 C=0.8344
gnomAD - Exomes American Sub 34588 G=0.1743 C=0.8257
gnomAD - Exomes African Sub 16254 G=0.1781 C=0.8219
gnomAD - Exomes Ashkenazi Jewish Sub 10076 G=0.3539 C=0.6461
gnomAD - Exomes Other Sub 6140 G=0.343 C=0.657
TopMed Global Study-wide 125568 G=0.31228 C=0.68772
ExAC Global Study-wide 121380 G=0.31662 C=0.68338
ExAC Europe Sub 73332 G=0.4112 C=0.5888
ExAC Asian Sub 25164 G=0.1681 C=0.8319
ExAC American Sub 11570 G=0.1658 C=0.8342
ExAC African Sub 10406 G=0.1777 C=0.8223
ExAC Other Sub 908 G=0.31 C=0.69
The PAGE Study Global Study-wide 78666 G=0.1979 C=0.8021
The PAGE Study AfricanAmerican Sub 32498 G=0.1897 C=0.8103
The PAGE Study Mexican Sub 10806 G=0.1881 C=0.8119
The PAGE Study Asian Sub 8318 G=0.079 C=0.921
The PAGE Study PuertoRican Sub 7914 G=0.273 C=0.727
The PAGE Study NativeHawaiian Sub 4526 G=0.196 C=0.804
The PAGE Study Cuban Sub 4230 G=0.327 C=0.673
The PAGE Study Dominican Sub 3828 G=0.257 C=0.743
The PAGE Study CentralAmerican Sub 2448 G=0.169 C=0.831
The PAGE Study SouthAmerican Sub 1982 G=0.186 C=0.814
The PAGE Study NativeAmerican Sub 1260 G=0.288 C=0.712
The PAGE Study SouthAsian Sub 856 G=0.18 C=0.82
gnomAD - Genomes Global Study-wide 31360 G=0.3317 C=0.6683
gnomAD - Genomes European Sub 18874 G=0.4215 C=0.5785
gnomAD - Genomes African Sub 8704 G=0.187 C=0.813
gnomAD - Genomes East Asian Sub 1558 G=0.102 C=0.898
gnomAD - Genomes Other Sub 1086 G=0.350 C=0.650
gnomAD - Genomes American Sub 848 G=0.21 C=0.79
gnomAD - Genomes Ashkenazi Jewish Sub 290 G=0.36 C=0.64
1000Genomes Global Study-wide 5008 G=0.204 C=0.796
1000Genomes African Sub 1322 G=0.136 C=0.864
1000Genomes East Asian Sub 1008 G=0.073 C=0.927
1000Genomes Europe Sub 1006 G=0.410 C=0.590
1000Genomes South Asian Sub 978 G=0.19 C=0.81
1000Genomes American Sub 694 G=0.24 C=0.76
Genetic variation in the Estonian population Estonian Study-wide 4480 G=0.424 C=0.576
A Vietnamese Genetic Variation Database Global Study-wide 614 G=0.07 C=0.93
Northern Sweden ACPOP Study-wide 600 G=0.41 C=0.59
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement G= C T Note
GRCh38.p12 chr 5 NC_000005.10:g.14...

NC_000005.10:g.148826910=

NC_000005.10:g.14...

NC_000005.10:g.148826910G>C

NC_000005.10:g.14...

NC_000005.10:g.148826910G>T

GRCh37.p13 chr 5 NC_000005.9:g.148...

NC_000005.9:g.148206473=

NC_000005.9:g.148...

NC_000005.9:g.148206473G>C

NC_000005.9:g.148...

NC_000005.9:g.148206473G>T

ADRB2 RefSeqGene NG_016421.1:g.531...

NG_016421.1:g.5318C>G

NG_016421.1:g.5318= NG_016421.1:g.531...

NG_016421.1:g.5318C>T

ADRB2 transcript NM_000024.5:c.79C>G NM_000024.5:c.79= NM_000024.5:c.79C>T
beta-2 adrenergic receptor NP_000015.1:p.Gln...

NP_000015.1:p.Gln27Glu

NP_000015.1:p.Gln27= NP_000015.1:p.Gln...

NP_000015.1:p.Gln27Ter

Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

145 SubSNP, 13 Frequency, 3 ClinVar submissions
No Submitter Submission ID Date (Build)
1 LEE ss1510176 Oct 05, 2000 (86)
2 HGBASE ss2420113 Nov 14, 2000 (89)
3 LEE ss4404104 May 29, 2002 (106)
4 WIPGA ss4915876 Aug 28, 2002 (108)
5 WI_SSAHASNP ss11700483 Jul 11, 2003 (116)
6 HG_BONN_CNS_SNPS ss12586696 Aug 26, 2003 (117)
7 CSHL-HAPMAP ss17068916 Feb 27, 2004 (120)
8 CSHL-HAPMAP ss17844407 Feb 27, 2004 (120)
9 SSAHASNP ss22345692 Apr 05, 2004 (121)
10 IMCJ-GDT ss22886616 Apr 05, 2004 (121)
11 PERLEGEN ss24683414 Sep 20, 2004 (123)
12 MGC_GENOME_DIFF ss28497723 Sep 24, 2004 (126)
13 MGC_GENOME_DIFF ss28512485 Sep 24, 2004 (126)
14 MGC_GENOME_DIFF ss28514035 Sep 24, 2004 (126)
15 ABI ss42409570 Mar 10, 2006 (126)
16 PGA-UW-FHCRC ss46533168 Mar 10, 2006 (126)
17 SNP500CANCER ss48292445 Mar 10, 2006 (126)
18 APPLERA_GI ss48427717 Mar 10, 2006 (126)
19 UCSF_HG ss49783231 Mar 10, 2006 (126)
20 RIKENSNPRC ss49847811 Mar 10, 2006 (126)
21 ILLUMINA ss65724638 Oct 15, 2006 (127)
22 PHARMGKB_PCE ss69365436 May 17, 2007 (127)
23 PHARMGKB_CREATE ss69366350 May 17, 2007 (127)
24 PHARMGKB_CREATE ss69366485 May 17, 2007 (127)
25 PHARMGKB_PAAR-SJCRH ss69367537 May 17, 2007 (127)
26 PHARMGKB_PHAT ss69368005 May 17, 2007 (127)
27 PHARMGKB_INVEST ss69368619 May 17, 2007 (127)
28 PHARMGKB_APP ss69369610 May 17, 2007 (127)
29 PHARMGKB_APP ss69369809 May 17, 2007 (127)
30 PHARMGKB_APP ss69370066 May 17, 2007 (127)
31 PHARMGKB_APP ss69370302 May 17, 2007 (127)
32 TAPPERS ss69371810 May 17, 2007 (127)
33 AFFY ss74806743 Aug 16, 2007 (128)
34 HGSV ss80218693 Dec 15, 2007 (130)
35 PHARMGKB_GERA ss84169997 Dec 15, 2007 (130)
36 BCMHGSC_JDW ss93286312 Mar 24, 2008 (129)
37 HUMANGENOME_JCVI ss98775117 Feb 06, 2009 (130)
38 PHARMGKB_PEAR ss105108112 Feb 06, 2009 (130)
39 PHARMGKB_INVEST ss105110338 Feb 06, 2009 (130)
40 PHARMGKB_INVEST ss105110339 Feb 06, 2009 (130)
41 BGI ss105958863 Feb 06, 2009 (130)
42 1000GENOMES ss109502589 Jan 24, 2009 (130)
43 1000GENOMES ss113428998 Jan 25, 2009 (130)
44 ILLUMINA-UK ss116853631 Feb 14, 2009 (130)
45 ILLUMINA ss120037417 Dec 01, 2009 (131)
46 ENSEMBL ss143519825 Dec 01, 2009 (131)
47 ILLUMINA ss152723832 Dec 01, 2009 (131)
48 GMI ss156154952 Dec 01, 2009 (131)
49 ILLUMINA ss159100432 Dec 01, 2009 (131)
50 ILLUMINA ss159123186 Dec 01, 2009 (131)
51 SEATTLESEQ ss159710482 Dec 01, 2009 (131)
52 COMPLETE_GENOMICS ss162755504 Jul 04, 2010 (132)
53 COMPLETE_GENOMICS ss165962400 Jul 04, 2010 (132)
54 ILLUMINA ss170065532 Jul 04, 2010 (132)
55 PHARMGKB_PHAT ss181129037 Jul 04, 2010 (132)
56 BUSHMAN ss201006933 Jul 04, 2010 (132)
57 BCM-HGSC-SUB ss206849987 Jul 04, 2010 (132)
58 1000GENOMES ss222028644 Jul 14, 2010 (132)
59 1000GENOMES ss233192412 Jul 14, 2010 (132)
60 1000GENOMES ss240305954 Jul 15, 2010 (132)
61 ILLUMINA ss244268887 Jul 04, 2010 (132)
62 BL ss253877617 May 09, 2011 (134)
63 RSG_JCVI ss262866273 May 09, 2011 (134)
64 OMICIA ss275516157 Nov 30, 2010 (133)
65 OMIM-CURATED-RECORDS ss275517991 Dec 03, 2010 (133)
66 GMI ss278525022 May 04, 2012 (137)
67 GMI ss285280529 Apr 25, 2013 (138)
68 PJP ss293490463 May 09, 2011 (134)
69 NHLBI-ESP ss342193382 May 09, 2011 (134)
70 ILLUMINA ss483715708 May 04, 2012 (137)
71 ILLUMINA ss484957687 May 04, 2012 (137)
72 1000GENOMES ss490913370 May 04, 2012 (137)
73 EXOME_CHIP ss491373623 May 04, 2012 (137)
74 CLINSEQ_SNP ss491875587 May 04, 2012 (137)
75 ILLUMINA ss535916639 Sep 08, 2015 (146)
76 TISHKOFF ss558785525 Apr 25, 2013 (138)
77 SSMP ss652689237 Apr 25, 2013 (138)
78 ILLUMINA ss779514733 Sep 08, 2015 (146)
79 ILLUMINA ss780842351 Sep 08, 2015 (146)
80 ILLUMINA ss782301378 Sep 08, 2015 (146)
81 ILLUMINA ss783525721 Sep 08, 2015 (146)
82 ILLUMINA ss832635905 Jul 13, 2019 (153)
83 ILLUMINA ss834985137 Sep 08, 2015 (146)
84 JMKIDD_LAB ss974457597 Aug 21, 2014 (142)
85 EVA-GONL ss982244497 Aug 21, 2014 (142)
86 JMKIDD_LAB ss1067472510 Aug 21, 2014 (142)
87 JMKIDD_LAB ss1073130453 Aug 21, 2014 (142)
88 1000GENOMES ss1317693447 Aug 21, 2014 (142)
89 DDI ss1430535520 Apr 01, 2015 (144)
90 EVA_GENOME_DK ss1581396235 Apr 01, 2015 (144)
91 EVA_FINRISK ss1584041838 Apr 01, 2015 (144)
92 EVA_DECODE ss1591776848 Apr 01, 2015 (144)
93 EVA_UK10K_ALSPAC ss1614268114 Apr 01, 2015 (144)
94 EVA_UK10K_ALSPAC ss1614268115 Apr 01, 2015 (144)
95 EVA_UK10K_TWINSUK ss1657262147 Apr 01, 2015 (144)
96 EVA_UK10K_TWINSUK ss1657262148 Apr 01, 2015 (144)
97 EVA_EXAC ss1688029160 Apr 01, 2015 (144)
98 EVA_MGP ss1711101806 Apr 01, 2015 (144)
99 HAMMER_LAB ss1804132075 Sep 08, 2015 (146)
100 ILLUMINA ss1917795748 Feb 12, 2016 (147)
101 WEILL_CORNELL_DGM ss1925498522 Feb 12, 2016 (147)
102 ILLUMINA ss1958832774 Feb 12, 2016 (147)
103 GENOMED ss1970234530 Jul 19, 2016 (147)
104 JJLAB ss2023356560 Sep 14, 2016 (149)
105 ILLUMINA ss2095164420 Dec 20, 2016 (150)
106 USC_VALOUEV ss2151515051 Dec 20, 2016 (150)
107 HUMAN_LONGEVITY ss2279156585 Dec 20, 2016 (150)
108 TOPMED ss2447475622 Dec 20, 2016 (150)
109 SYSTEMSBIOZJU ss2626166628 Nov 08, 2017 (151)
110 ILLUMINA ss2634354528 Nov 08, 2017 (151)
111 GRF ss2707084332 Nov 08, 2017 (151)
112 ILLUMINA ss2711051570 Nov 08, 2017 (151)
113 GNOMAD ss2735340123 Nov 08, 2017 (151)
114 GNOMAD ss2747484745 Nov 08, 2017 (151)
115 GNOMAD ss2832147595 Nov 08, 2017 (151)
116 AFFY ss2985339160 Nov 08, 2017 (151)
117 AFFY ss2985970870 Nov 08, 2017 (151)
118 SWEGEN ss2997982677 Nov 08, 2017 (151)
119 ILLUMINA ss3022540967 Nov 08, 2017 (151)
120 EVA_SAMSUNG_MC ss3023061571 Nov 08, 2017 (151)
121 BIOINF_KMB_FNS_UNIBA ss3025460093 Nov 08, 2017 (151)
122 CSHL ss3346678471 Nov 08, 2017 (151)
123 TOPMED ss3481827033 Nov 08, 2017 (151)
124 ILLUMINA ss3629367634 Oct 12, 2018 (152)
125 ILLUMINA ss3629367635 Oct 12, 2018 (152)
126 ILLUMINA ss3632277641 Oct 12, 2018 (152)
127 ILLUMINA ss3635027931 Oct 12, 2018 (152)
128 ILLUMINA ss3638587579 Oct 12, 2018 (152)
129 ILLUMINA ss3640735225 Oct 12, 2018 (152)
130 ILLUMINA ss3644891853 Oct 12, 2018 (152)
131 OMUKHERJEE_ADBS ss3646326217 Oct 12, 2018 (152)
132 URBANLAB ss3648194723 Oct 12, 2018 (152)
133 ILLUMINA ss3653043946 Oct 12, 2018 (152)
134 ILLUMINA ss3653043947 Oct 12, 2018 (152)
135 ILLUMINA ss3654111346 Oct 12, 2018 (152)
136 EGCUT_WGS ss3665902715 Jul 13, 2019 (153)
137 PATHPUNJABI ss3685990253 Jul 13, 2019 (153)
138 EVA_DECODE ss3715930581 Jul 13, 2019 (153)
139 ILLUMINA ss3726280662 Jul 13, 2019 (153)
140 ACPOP ss3732916314 Jul 13, 2019 (153)
141 ILLUMINA ss3744541930 Jul 13, 2019 (153)
142 ILLUMINA ss3745328105 Jul 13, 2019 (153)
143 EVA ss3764207363 Jul 13, 2019 (153)
144 PAGE_CC ss3771239016 Jul 13, 2019 (153)
145 KHV_HUMAN_GENOMES ss3807376595 Jul 13, 2019 (153)
146 1000Genomes NC_000005.9 - 148206473 Oct 12, 2018 (152)
147 The Avon Longitudinal Study of Parents and Children

Submission ignored due to conflicting rows:
Row 16351763 (NC_000005.9:148206472:G:G 1676/3854, NC_000005.9:148206472:G:C 2178/3854)
Row 16351764 (NC_000005.9:148206472:G:G 3853/3854, NC_000005.9:148206472:G:T 1/3854)

- Oct 12, 2018 (152)
148 The Avon Longitudinal Study of Parents and Children

Submission ignored due to conflicting rows:
Row 16351763 (NC_000005.9:148206472:G:G 1676/3854, NC_000005.9:148206472:G:C 2178/3854)
Row 16351764 (NC_000005.9:148206472:G:G 3853/3854, NC_000005.9:148206472:G:T 1/3854)

- Oct 12, 2018 (152)
149 Genetic variation in the Estonian population NC_000005.9 - 148206473 Oct 12, 2018 (152)
150 ExAC NC_000005.9 - 148206473 Oct 12, 2018 (152)
151 gnomAD - Genomes NC_000005.9 - 148206473 Jul 13, 2019 (153)
152 gnomAD - Exomes NC_000005.9 - 148206473 Jul 13, 2019 (153)
153 Northern Sweden NC_000005.9 - 148206473 Jul 13, 2019 (153)
154 The PAGE Study NC_000005.10 - 148826910 Jul 13, 2019 (153)
155 TopMed NC_000005.10 - 148826910 Oct 12, 2018 (152)
156 UK 10K study - Twins

Submission ignored due to conflicting rows:
Row 16351763 (NC_000005.9:148206472:G:G 1647/3708, NC_000005.9:148206472:G:C 2061/3708)
Row 16351764 (NC_000005.9:148206472:G:G 3708/3708, NC_000005.9:148206472:G:T 0/3708)

- Oct 12, 2018 (152)
157 UK 10K study - Twins

Submission ignored due to conflicting rows:
Row 16351763 (NC_000005.9:148206472:G:G 1647/3708, NC_000005.9:148206472:G:C 2061/3708)
Row 16351764 (NC_000005.9:148206472:G:G 3708/3708, NC_000005.9:148206472:G:T 0/3708)

- Oct 12, 2018 (152)
158 A Vietnamese Genetic Variation Database NC_000005.9 - 148206473 Jul 13, 2019 (153)
159 ClinVar RCV000019318.2 Oct 12, 2018 (152)
160 ClinVar RCV000019319.2 Oct 12, 2018 (152)
161 ClinVar RCV000033191.3 Jul 13, 2019 (153)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs3182175 Jul 03, 2002 (106)
rs3729941 Oct 08, 2002 (108)
rs17287411 Mar 10, 2006 (126)
rs17287474 Mar 10, 2006 (126)
rs17334200 Mar 10, 2006 (126)
rs17640526 Oct 08, 2004 (123)
rs17845338 Mar 10, 2006 (126)
rs17858183 Mar 10, 2006 (126)
rs17859733 Mar 10, 2006 (126)
rs52793394 Sep 21, 2007 (128)
rs60374884 May 25, 2008 (130)
Added to this RefSNP Cluster:
Submission ids Observation SPDI Canonical SPDI Source RSIDs
ss80218693, ss93286312, ss109502589, ss113428998, ss116853631, ss162755504, ss165962400, ss201006933, ss206849987, ss253877617, ss278525022, ss285280529, ss293490463, ss484957687, ss491875587, ss1591776848 NC_000005.8:148186665:G:C NC_000005.10:148826909:G:C (self)
29388921, 11640963, 8038243, 80415640, 4471250, 6201179, 3624067, ss222028644, ss233192412, ss240305954, ss342193382, ss483715708, ss490913370, ss491373623, ss535916639, ss558785525, ss652689237, ss779514733, ss780842351, ss782301378, ss783525721, ss832635905, ss834985137, ss974457597, ss982244497, ss1067472510, ss1073130453, ss1317693447, ss1430535520, ss1581396235, ss1584041838, ss1614268114, ss1657262147, ss1688029160, ss1711101806, ss1804132075, ss1917795748, ss1925498522, ss1958832774, ss1970234530, ss2023356560, ss2095164420, ss2151515051, ss2447475622, ss2626166628, ss2634354528, ss2707084332, ss2711051570, ss2735340123, ss2747484745, ss2832147595, ss2985339160, ss2985970870, ss2997982677, ss3022540967, ss3023061571, ss3346678471, ss3629367634, ss3629367635, ss3632277641, ss3635027931, ss3638587579, ss3640735225, ss3644891853, ss3646326217, ss3653043946, ss3653043947, ss3654111346, ss3665902715, ss3732916314, ss3744541930, ss3745328105, ss3764207363 NC_000005.9:148206472:G:C NC_000005.10:148826909:G:C (self)
460485, 325341364, ss275516157, ss275517991, ss2279156585, ss3025460093, ss3481827033, ss3648194723, ss3685990253, ss3715930581, ss3726280662, ss3771239016, ss3807376595 NC_000005.10:148826909:G:C NC_000005.10:148826909:G:C (self)
ss11700483 NT_029289.9:9369409:G:C NC_000005.10:148826909:G:C (self)
ss17068916, ss17844407, ss22345692 NT_029289.10:9369408:G:C NC_000005.10:148826909:G:C (self)
ss1510176, ss2420113, ss4404104, ss4915876, ss12586696, ss22886616, ss24683414, ss28497723, ss28512485, ss28514035, ss42409570, ss46533168, ss48292445, ss48427717, ss49783231, ss49847811, ss65724638, ss69365436, ss69366350, ss69366485, ss69367537, ss69368005, ss69368619, ss69369610, ss69369809, ss69370066, ss69370302, ss69371810, ss74806743, ss84169997, ss98775117, ss105108112, ss105110338, ss105110339, ss105958863, ss120037417, ss143519825, ss152723832, ss156154952, ss159100432, ss159123186, ss159710482, ss170065532, ss181129037, ss244268887, ss262866273 NT_029289.11:9369399:G:C NC_000005.10:148826909:G:C (self)
ss1614268115, ss1657262148 NC_000005.9:148206472:G:T NC_000005.10:148826909:G:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

150 citations for rs1042714
PMID Title Author Year Journal
9275150 The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. Dewar JC et al. 1997 The Journal of allergy and clinical immunology
9399946 Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. Large V et al. 1997 The Journal of clinical investigation
9399966 Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. Martinez FD et al. 1997 The Journal of clinical investigation
9522789 Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. Hopes E et al. 1998 BMJ (Clinical research ed.)
12030897 The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Corbalán MS et al. 2002 Clinical genetics
14557466 The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. Dallongeville J et al. 2003 The Journal of clinical endocrinology and metabolism
15500681 Detecting imbalanced expression of SNP alleles by minisequencing on microarrays. Liljedahl U et al. 2004 BMC biotechnology
15726497 Gene-environment interaction effects on the development of immune responses in the 1st year of life. Hoffjan S et al. 2005 American journal of human genetics
15867853 Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. Contopoulos-Ioannidis DG et al. 2005 The Journal of allergy and clinical immunology
16385446 A testing framework for identifying susceptibility genes in the presence of epistasis. Millstein J et al. 2006 American journal of human genetics
16600026 Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Wjst M et al. 2006 Respiratory research
16642433 Polymorphism in maternal LRP8 gene is associated with fetal growth. Wang L et al. 2006 American journal of human genetics
16741943 Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Diatchenko L et al. 2006 American journal of medical genetics. Part B, Neuropsychiatric genetics
16935688 Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study. Hall IP et al. 2006 Lancet (London, England)
17143563 beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease. Jazdzewski K et al. 2007 International journal of molecular medicine
17150099 Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. Pinelli M et al. 2006 BMC medical genetics
17199132 beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Cheslack-Postava K et al. 2007 Molecular psychiatry
17512307 Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Lima JJ et al. 2007 Metabolism
18279468 Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure. Zakrzewski-Jakubiak M et al. 2008 British journal of clinical pharmacology
18304332 No evidence for association between BMI and 10 candidate genes at ages 4, 7 and 10 in a large UK sample of twins. Haworth CM et al. 2008 BMC medical genetics
18513389 New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. Penco S et al. 2008 BMC bioinformatics
18534365 Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Tseng ZH et al. 2008 Heart rhythm
18599530 Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients. Feng Y et al. 2008 Diabetes care
18603647 Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Simoni M et al. 2008 Human reproduction update
18611262 Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Feigelson HS et al. 2008 Breast cancer research
18615004 beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension. Pacanowski MA et al. 2008 Clinical pharmacology and therapeutics
18625943 Intraocular pressure response to topical beta-blockers associated with an ADRB2 single-nucleotide polymorphism. McCarty CA et al. 2008 Archives of ophthalmology (Chicago, Ill.
18640383 Genotypes and haplotypes of beta2-adrenergic receptor and parameters of the metabolic syndrome in Korean adolescents. Park HS et al. 2008 Metabolism
18647184 Association between polymorphisms in the beta2-adrenoceptor gene and migraine in women. Schürks M et al. 2009 Headache
18709160 Interactions between glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic disease. Melén E et al. 2008 Environmental health perspectives
18719656
18936436 Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Chang MH et al. 2009 American journal of epidemiology
19111454 Genetic association analysis of COPD candidate genes with bronchodilator responsiveness. Kim WJ et al. 2009 Respiratory medicine
19131662 A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Wang X et al. 2009 Stroke
19186333 Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis. Jalba MS et al. 2008 Obesity (Silver Spring, Md.)
19190821 Association between polymorphisms in the beta2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women. Schürks M et al. 2009 Thrombosis and haemostasis
19263529 Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Zee RY et al. 2009 Clinica chimica acta; international journal of clinical chemistry
19284637 Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence. Chu X et al. 2009 BMC medical genetics
19330901 Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. Conen D et al. 2009 Journal of hypertension
19379518 Development of a fingerprinting panel using medically relevant polymorphisms. Cross DS et al. 2009 BMC medical genomics
19553224 Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance. Santiago C et al. 2011 British journal of sports medicine
19559392 A candidate gene association study of 77 polymorphisms in migraine. Schürks M et al. 2009 The journal of pain
19565482 Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains. Vargas-Alarcón G et al. 2009 Arthritis and rheumatism
19576569 Diverse evolutionary histories for beta-adrenoreceptor genes in humans. Cagliani R et al. 2009 American journal of human genetics
19619703 Association of genetic variants with the metabolic syndrome in 20,806 white women: The Women's Health Genome Study. Goulart AC et al. 2009 American heart journal
19717003 Pediatric obesity: etiology and treatment. Crocker MK et al. 2009 Endocrinology and metabolism clinics of North America
19730237 Personalized medicine: genetic variation and loss of physiologic complexity are associated with mortality in 644 trauma patients. Norris PR et al. 2009 Annals of surgery
19736300 Genetic basis of inter-individual variability in the effects of exercise on the alleviation of lifestyle-related diseases. Mori M et al. 2009 The Journal of physiology
19779622 No consistent effect of ADRB2 haplotypes on obesity, hypertension and quantitative traits of body fatness and blood pressure among 6,514 adult Danes. Gjesing AP et al. 2009 PloS one
19933216 The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Castaldi PJ et al. 2010 Human molecular genetics
20049212 Traffic-related air pollution, oxidative stress genes, and asthma (ECHRS). Castro-Giner F et al. 2009 Environmental health perspectives
20142250 Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study. Meyer TE et al. 2010 Cancer epidemiology, biomarkers & prevention
20230274 Polymorphisms in the ACE and ADRB2 genes and risks of aging-associated phenotypes: the case of myocardial infarction. Kulminski AM et al. 2010 Rejuvenation research
20401335 Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype. Driss A et al. 2009 Genomics insights
20417488 Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Clark EA et al. 2010 American journal of obstetrics and gynecology
20435227 Clinical assessment incorporating a personal genome. Ashley EA et al. 2010 Lancet (London, England)
20521218 Progress toward genetic tailoring of heart failure therapy. Lillvis JH et al. 2010 Current opinion in molecular therapeutics
20523301 Role of β₂-adrenergic receptor polymorphisms on body weight and body composition response to energy restriction in obese women: preliminary results. Ruiz JR et al. 2011 Obesity (Silver Spring, Md.)
20537997 Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. Loomba R et al. 2010 Gastroenterology
20565774 Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. Cross DS et al. 2010 BMC genetics
20592916 Pharmacogenomic approaches to asthma treatment. Cho SH et al. 2010 Allergy, asthma & immunology research
20810793 Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Bambha K et al. 2010 Mayo Clinic proceedings
20816195 Analyses of shared genetic factors between asthma and obesity in children. Melén E et al. 2010 The Journal of allergy and clinical immunology
20869266 Single-nucleotide polymorphisms in the β-adrenergic receptor genes are associated with lung allograft utilization. Sapru A et al. 2011 The Journal of heart and lung transplantation
20981351 Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study. Sugimoto K et al. 2010 International journal of hypertension
21054877 Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994. Ned RM et al. 2010 BMC medical genetics
21059181 Polymorphisms of adrenergic cardiovascular control genes are associated with adolescent chronic fatigue syndrome. Sommerfeldt L et al. 2011 Acta paediatrica (Oslo, Norway
21233812 ADRB2 and LEPR gene polymorphisms: synergistic effects on the risk of obesity in Japanese. Pereira TV et al. 2011 Obesity (Silver Spring, Md.)
21291465 The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Wu D et al. 2011 Developmental medicine and child neurology
21395649 Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients. Petersen M et al. 2011 British journal of clinical pharmacology
21414566 β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study. Vardeny O et al. 2011 Journal of the American Society of Hypertension
21437030 Genetics and cardiovascular system: influence of human genetic variants on vascular function. Dias RG et al. 2011 Genes & nutrition
21467728 Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: a project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. Wakai K et al. 2011 Journal of epidemiology
21515823 Genetic predictors for stroke in children with sickle cell anemia. Flanagan JM et al. 2011 Blood
21573230 Clustering heart rate dynamics is associated with β-adrenergic receptor polymorphisms: analysis by information-based similarity index. Yang AC et al. 2011 PloS one
21613201 The effect of maternal and fetal β2-adrenoceptor and nitric oxide synthase genotype on vasopressor requirement and fetal acid-base status during spinal anesthesia for cesarean delivery. Landau R et al. 2011 Anesthesia and analgesia
21807569 β-1 and β-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening. Wittwer ED et al. 2011 Autonomic neuroscience
21883537 β2 -adrenergic receptor Thr164IIe polymorphism, blood pressure and ischaemic heart disease in 66 750 individuals. Thomsen M et al. 2012 Journal of internal medicine
21894447 Are centenarians genetically predisposed to lower disease risk? Ruiz JR et al. 2012 Age (Dordrecht, Netherlands)
21981957 Pediatric obesity: etiology and treatment. Crocker MK et al. 2011 Pediatric clinics of North America
22024213 A novel gene-environment interaction involved in endometriosis. McCarty CA et al. 2012 International journal of gynaecology and obstetrics
22199155 Gender-dependent association of a β(2)-adrenergic gene variant with obesity parameters in Malaysian Malays. Apalasamy YD et al. 2015 Asia-Pacific journal of public health
22355322 Gene-gene and gene-environmental interactions of childhood asthma: a multifactor dimension reduction approach. Su MW et al. 2012 PloS one
22383665 ADRB2 polymorphisms and budesonide/formoterol responses in COPD. Bleecker ER et al. 2012 Chest
22552919 Bioinformatics and variability in drug response: a protein structural perspective. Lahti JL et al. 2012 Journal of the Royal Society, Interface
22559839 Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response. Ambrose HJ et al. 2012 Respiratory research
22624056 Genetic variation in the β2-adrenocepter gene is associated with susceptibility to bacterial meningitis in adults. Adriani KS et al. 2012 PloS one
22769019 Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population. Zhao N et al. 2012 Journal of neuroinflammation
22864926 ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity. Connor A et al. 2012 Cancer causes & control
22900502 Association between β2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS. Tellechea ML et al. 2013 Clinical endocrinology
22985077 Associations between genetic polymorphisms of beta-2 adrenergic receptor and preterm delivery in Korean women. Suh YJ et al. 2013 American journal of reproductive immunology (New York, N.Y.
23229623 ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936. Lyall DM et al. 2013 Behavior genetics
23229733 A functional SNP upstream of the beta-2 adrenergic receptor gene (ADRB2) is associated with obesity in Oceanic populations. Naka I et al. 2013 International journal of obesity (2005)
23267696 Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Chinese Han population: a case-control study. Guo Y et al. 2012 BMC medical genomics
23463918 Childhood lung function and the association with β2-adrenergic receptor haplotypes. Torjussen TM et al. 2013 Acta paediatrica (Oslo, Norway
23786226 Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of life. Kushnir VM et al. 2013 Alimentary pharmacology & therapeutics
23820649 Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Cooper DN et al. 2013 Human genetics
23911093 Association of the FTO and ADRB2 genes with body composition and fat distribution in obese women. Rauhio A et al. 2013 Maturitas
24012958 Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population. Saadi AV et al. 2013 Infection, genetics and evolution
24322328 Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor β2 surface gene on obesity and metabolic phenotypes in Taiwan. Hsiao TJ et al. 2014 Journal of investigative medicine
24392269 Gene-Lifestyle Interactions in Obesity. van Vliet-Ostaptchouk JV et al. 2012 Current nutrition reports
24624293 Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. Ong FS et al. 2013 Journal of personalized medicine
24714117 Polymorphism in the ADRB2 gene explains a small portion of intersubject variability in pain relative to cervical dilation in the first stage of labor. Terkawi AS et al. 2014 Anesthesiology
24960039 Association of Gln27Glu and Arg16Gly polymorphisms in Beta2-adrenergic receptor gene with obesity susceptibility: a meta-analysis. Zhang H et al. 2014 PloS one
25050782 Effects of β2-adrenergic receptor gene polymorphisms on ritodrine therapy in pregnant women with preterm labor: prospective follow-up study. Park JY et al. 2014 International journal of molecular sciences
25111792 Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies. Liang SQ et al. 2014 PloS one
25266489 Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China. Zhang J et al. 2014 BMC genetics
25761120 A genetic predisposition score associates with reduced aerobic capacity in response to acute normobaric hypoxia in lowlanders. Masschelein E et al. 2015 High altitude medicine & biology
25894531 Pharmacogenetic Effects of Inhaled Salbutamol on 10-km Time Trial Performance in Competitive Male and Female Cyclists. Koch S et al. 2016 Clinical journal of sport medicine
25910744 Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density. Veldhuis-Vlug AG et al. 2015 Osteoporosis international
26091847 Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China. Wang L et al. 2015 BMC genetics
26111150 Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension. Anthony EG et al. 2015 Pharmacogenetics and genomics
26146998 A Common Polymorphism of the Human Cardiac Sodium Channel Alpha Subunit (SCN5A) Gene Is Associated with Sudden Cardiac Death in Chronic Ischemic Heart Disease. Marcsa B et al. 2015 PloS one
26365620 Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men. Son KY et al. 2015 Lipids in health and disease
26369942 β2-Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study. Wu P et al. 2015 BMC medical genetics
26373931 Polymorphism profiling of nine high altitude relevant candidate gene loci in acclimatized sojourners and adapted natives. Tomar A et al. 2015 BMC genetics
26503814 A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease. Hardin M et al. 2016 The pharmacogenomics journal
26879662 Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study. Lee HY et al. 2016 The Korean journal of internal medicine
27103841 Personalized medicine and treatment approaches in hypertension: current perspectives. Byrd JB et al. 2016 Integrated blood pressure control
27233804 Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China. Jin T et al. 2016 BMC genetics
27247849 Genetic variation and cognitive dysfunction in opioid-treated patients with cancer. Kurita GP et al. 2016 Brain and behavior
27274104 A genetic-based algorithm for personalized resistance training. Jones N et al. 2016 Biology of sport
27411394 Shared genetic variants between serum levels of high-density lipoprotein cholesterol and wheezing in a cohort of children from Cyprus. Yiallouros PK et al. 2016 Italian journal of pediatrics
27515755 Study of seven single-nucleotide polymorphisms identified in East Asians for association with obesity in a Taiwanese population. Huang WH et al. 2016 BMJ open
27601774 Genetic variants influencing effectiveness of exercise training programmes in obesity - an overview of human studies. Leońska-Duniec A et al. 2016 Biology of sport
27616475 Gene variants as risk factors for gastroschisis. Padula AM et al. 2016 American journal of medical genetics. Part A
27624002 Allergy-specific Phenome-Wide Association Study for Immunogenes in Turkish Children. Karaca S et al. 2016 Scientific reports
27669015 Adrenergic Receptor Polymorphism and Maximal Exercise Capacity after Orthotopic Heart Transplantation. Métrich M et al. 2016 PloS one
27798356 Lack of replication of associations between multiple genetic polymorphisms and endurance athlete status in Japanese population. Yvert T et al. 2016 Physiological reports
28235084 Neurovascular control during exercise in acute coronary syndrome patients with Gln27Glu polymorphism of β2-adrenergic receptor. Ferreira-Santos L et al. 2017 PloS one
28327457 Beta<sub>2</sub>-adrenergic receptor gene haplotypes and bronchodilator response in Egyptian patients with chronic obstructive pulmonary disease. Hussein MH et al. 2017 Advances in medical sciences
28446801 Genetic susceptibility to salt-sensitive hypertension in a Han Chinese population: a validation study of candidate genes. Liu Z et al. 2017 Hypertension research
28738793 Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study. Sikhayeva N et al. 2017 BMC medical genetics
28753063 Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population. Zhao H et al. 2017 Genetic testing and molecular biomarkers
29132297 Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study. Chung JE et al. 2017 BMC genetics
29331538 Differential lipid metabolism outcomes associated with ADRB2 gene polymorphisms in response to two dietary interventions in overweight/obese subjects. Ramos-Lopez O et al. 2018 Nutrition, metabolism, and cardiovascular diseases
29519182 Interactions among insulin resistance, inflammation factors, obesity-related gene polymorphisms, environmental risk factors, and diet in the development of gestational diabetes mellitus. Feng Y et al. 2019 The journal of maternal-fetal & neonatal medicine
29550988 Genetic variants conferring susceptibility to gastroschisis: a phenomenon restricted to the interaction with the environment? Salinas-Torres VM et al. 2018 Pediatric surgery international
29620176 β2‑adrenergic receptor functionality and genotype in two different models of chronic inflammatory disease: Liver cirrhosis and osteoarthritis. Roca R et al. 2018 Molecular medicine reports
29992699 Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. Slob EMA et al. 2018 Pediatric allergy and immunology
30334910 Leveraging electronic health records to assess the role of ADRB2 single nucleotide polymorphisms in predicting exacerbation frequency in asthma patients. Sood N et al. 2018 Pharmacogenetics and genomics
30409984 Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics. John SE et al. 2018 Scientific reports
30468638 Beta<sub>2</sub>-adrenergic receptor variants in children and adolescents with bronchial asthma. Toraih EA et al. 2019 Frontiers in bioscience (Elite edition)
30485313 The magnitude of Yo-Yo test improvements following an aerobic training intervention are associated with total genotype score. Pickering C et al. 2018 PloS one
30542705 β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms. Xie WY et al. 2019 Oncology reports
30574349 Alignment of diet prescription to genotype does not promote greater weight loss success in women with obesity participating in an exercise and weight loss program. Coletta AM et al. 2018 Obesity science & practice
30668166 β<sub>2</sub>-Adrenergic Receptor Gene Polymorphisms Are Associated with Cardiovascular Events But not All-Cause Mortality in Coronary Artery Disease Patients: A Meta-Analysis of Prospective Studies. Li Y et al. 2019 Genetic testing and molecular biomarkers
30774389 Association of genetic variants with level of asthma control in the Arab population. Almomani BA et al. 2019 Journal of asthma and allergy
31056593 POLYMORPHISMS IN β-ADRENERGIC RECEPTORS ARE ASSOCIATED WITH INCREASED RISK TO HAVE A POSITIVE HEAD-UP TILT TABLE TEST IN PATIENTS WITH VASOVAGAL SYNCOPE. Márquez MF et al. 2019 Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
31090079 β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies. Shahin MH et al. 2019 Journal of clinical pharmacology

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post104+4a6ee9c